Antacids Market Companies, Leaders, Announcements and Trends
The global antacids market is projected to reach USD 7.47 billion in 2024 and is expected to grow to USD 10.33 billion by 2034, expanding at a CAGR of 3.30% from 2024 to 2034. This growth is driven by the increasing prevalence of gastroesophageal reflux disease (GERD) and the enhanced availability and accessibility of over-the-counter (OTC) medications.
Download statistics of this report @ https://www.towardshealthcare.com/download-statistics/5079
Antacids Market Trends Key Drivers and Innovations
Rising Incidence of Acid Reflux: The growing number of cases of acid reflux and gastroesophageal reflux disease (GERD), often linked to sedentary lifestyles, is a major factor driving the expansion of the antacids market.
Aging Population: As the global population ages, the demand for antacids increases. This is because the production of stomach acids tends to decrease with age, leading to more people seeking relief from acidity.
Advancements in Research and Development: Ongoing research and development efforts are pushing the boundaries of antacid solutions. Companies are focusing on discovering new active ingredients and exploring novel drug delivery methods to improve treatment efficacy.
Availability of Generic Formulations: The widespread availability of generic antacid drugs, which are cost-effective alternatives to branded options, is also boosting the demand for antacids.
AI Transforming the Antacids Market: Fueling Growth and Innovation
The use of artificial intelligence (AI) in the antacids market is driving both growth and innovation. AI is making it easier to conduct research and development by analyzing large datasets, which helps in discovering new ingredients and optimizing formulations for better results with fewer side effects. This speeds up the development process, enabling companies to introduce new and improved antacid products more quickly.
AI is also enabling personalized medicine in the antacids sector. By examining individual patient data, AI can help tailor antacid treatments to meet specific needs, improving the effectiveness of treatments and patient satisfaction. Additionally, AI-driven predictive analytics are providing insights into market trends, consumer preferences, and potential industry shifts, helping businesses make more informed decisions.
On the manufacturing side, AI is enhancing efficiency. Automated systems and advanced algorithms are improving production lines by ensuring consistency and high quality, all while reducing operational costs.
Recent Announcements and Developments from Industry Leaders
Sanjeev Jain, Managing Director of Akums Drugs & Pharmaceuticals Ltd., recently discussed the launch of their new antacid product in India. He emphasized the need for advanced treatment options due to the rising prevalence of GERD and its complications. The new product, according to Jain, offers a unique solution by not only neutralizing stomach acid but also forming a protective layer.
Noteworthy Industry Developments
- In July 2024, Dr. Reddy’s Laboratories entered into a non-exclusive patent licensing agreement with Japan’s Takeda Pharmaceutical Co. to bring Vonoprazan, a novel antacid drug, to the Indian market.
- In the same month, Chula Medicine, in collaboration with the Department of Thai Traditional and Alternative Medicine and gastroenterologists, announced the success of a clinical study that demonstrated the effectiveness of Thai curcumin in treating dyspepsia.
Antacids Market Companies
- Bayer AG
- GlaxoSmithKline Plc.
- Takeda Pharmaceutical Company Ltd.
- Sun Pharmaceutical Industries Ltd.
- Dr Reddy’s Laboratories Ltd.
- Pfizer Inc.
- Reckitt Benckiser Group Plc.
- Cipla Ltd.
- Alkem Laboratories Ltd.
- Abbott Laboratories
Our Table of Content (TOC) covers key healthcare market segments, materials, technologies and trends—helping you navigate market shifts and make informed decisions: https://www.towardshealthcare.com/table-of-content/antacids-market-size
Access exclusive insight now @ https://www.towardshealthcare.com/price/5079
We’ve prepared a service to support you. Please feel free to contact us at sales@towardshealthcare.com
Web: https://www.towardshealthcare.com
Visit Dental Specifics: https://www.towardsdental.com
Get the latest insights on industry segmentation with our Annual Membership: Get a Subscription
For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare
